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Abstract
Organophosphonates such as isopropyl metylphosphonofluoridate (sarin) are extremely toxic as they phosphonylate the
catalytic serine residue of acetylcholinesterase (AChE), an enzyme essential to humans and other species. Design of effective
AChE reactivators as antidotes to various organophosphonates requires information on how the reactivators interact with
the phosphonylated AChEs. However, such information has not been available hitherto because of three main challenges.
First, reactivators are generally flexible in order to change from the ground state to the transition state for reactivation; this
flexibility discourages determination of crystal structures of AChE in complex with effective reactivators that are intrinsically
disordered. Second, reactivation occurs upon binding of a reactivator to the phosphonylated AChE. Third, the phosphorous
conjugate can develop resistance to reactivation. We have identified crystallographic conditions that led to the
determination of a crystal structure of the sarin
nonaged-conjugated mouse AChE in complex with [(E)-[1-[(4-
carbamoylpyridin-1-ium-1-yl)methoxymethyl]pyridin-2-ylidene]methyl]-oxoazanium dichloride (HI-6) at a resolution of
2.2 A ˚. In this structure, the carboxyamino-pyridinium ring of HI-6 is sandwiched by Tyr124 and Trp286, however, the oxime-
pyridinium ring is disordered. By combining crystallography with microsecond molecular dynamics simulation, we
determined the oxime-pyridinium ring structure, which shows that the oxime group of HI-6 can form a hydrogen-bond
network to the sarin isopropyl ether oxygen, and a water molecule is able to form a hydrogen bond to the catalytic histidine
residue and subsequently deprotonates the oxime for reactivation. These results offer insights into the reactivation
mechanism of HI-6 and design of better reactivators.
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Introduction
Acetylcholinesterase (AChE) terminates cholinergic transmis-
sion by rapidly hydrolyzing the neurotransmitter acetylcholine,
and it is an essential enzyme for humans and other species [1].
The catalytic triad in this enzyme consists of Ser203, His447 and
Glu334 located at the bottom of a ,20-A ˚-deep active-site gorge
[2,3], where the residue numbers are based on the sequence
numbering of mouse AChE (mAChE) that is used throughout this
paper. Organophosphates or organophosphonates (OPs), used as
insecticides and nerve agents, irreversibly inhibit AChE by
phosphonylating the catalytic serine residue (Figure 1) [1]. One
key step of current treatment of OP intoxication is to use oximes as
nucleophiles to reactivate AChE by removing the phosphorous
conjugate [4]. The oxime therapy is, however, limited by two main
complications in addition to limitations such as low membrane
permeability of oximes containing quaternary ammoniums. First,
the reactivation efficiency depends on structures of OPs and
reactivators as well as sequence variations in the AChE active site
[5-10]. For example, [(E)-[1-[(4-carbamoylpyridin-1-ium-1-yl)-
methoxymethyl]pyridin-2-ylidene]methyl]-oxoazanium dichloride
(HI-6) is an efficient oxime reactivator of AChEs conjugated to
isopropyl metylphosphonofluoridate (sarin) but not to AChEs
conjugated to ethyl N,N-dimethylphosphoramidocyanidate (tabun)
[8]. Reactivator oxo-[[1-[[4-(oxoazaniumylmethylidene)pyridin-1-
yl]methoxymethyl]pyridin-4-ylidene]methyl]azanium (obidoxime)
reactivates both sarin- and tabun-conjugated AChEs more
effectively than HI-6. Second, many OP conjugates can undergo
an ‘‘aging’’ process that eliminates one of their substituents
(Figure 1). Aged conjugates are resistant to current oxime
reactivators [11,12]. Therefore, more effective AChE reactivators
as antidotes to a wide range of OPs are highly desirable.
Oximes such as [(E)-(1-methylpyridin-2-ylidene)methyl]-oxoa-
zanium chloride (pralidoxime), HI-6, and obidoxime have been
used in the clinic to treat intoxication by certain OPs for decades
[13,14], but little is known about reactivation mechanisms for
these oximes at the structural level. For example, the pKa values of
these oximes are 7.3–8.0 [15–17]. These oximes are likely
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5957protonated in the AChE active site, although deprotonated oximes
in AChE have been proposed [18]. If oximes are protonated in
AChE, where is the base that deprotonates the oximes before
reactivation? If oximes have relatively low pKa values and are
deprotonated in the absence of a base in the active site, can these
oximes be more nucleophilic than the catalytic serine hydroxyl
group to drive the reactivation to completion? Furthermore, there
is no available information on how the reactivators change from
the Michaelis-Menten state to the transition state for reactivation,
wherein the Michaelis-Menten state is defined as the ground state
that can directly proceed to the transition state of the chemical
reaction [19].
The lack of such information has hampered the structure-based
design of more effective AChE reactivators. In our view, this
paucity is due to three main challenges. First, unlike enzyme
inhibitors, reactivators have to be flexible or mobile in order to be
able to change from the Michaelis-Menten state to the transition
state; this flexibility often translates to mobility that discourages
determination of crystal structures of AChE in complex with
effective reactivators because the reactivators are intrinsically
disordered. Second, reactivation occurs immediately upon binding
of a reactivator to the phosphonylated AChE. Third, aging can
occur before reactivation, which enables determination of
complexes of reactivator-bound AChEs with aged conjugates but
prevents obtaining direct information with regard to reactivation
mechanisms.
In this article, we report a structure of the sarin
nonaged-
conjugated mAChE in complex with HI-6 (HI-6Nsarin
nonaged-
mAChE) at the Michaelis-Menten state and supporting crystal
structures of the corresponding aged complex (HI-6Nsarin
aged-
mAChE) and mAChE in complex with (E)-4-carbamoyl-1-{3-[4-
(hydroxyiminomethyl)pyridinium-1-yl]propyl}pyridinium bro-
mide (K027NmAChE). We also report our approach of combining
crystallography with microsecond molecular dynamics simulation
used to determine the Michaelis-Menten complex structure and
supportive reactivation kinetics results. We discuss the insights
from these structures into the reactivation mechanism of HI-6 and
design of improved reactivators.
Results
General description of three reactivator-bound mAChE
crystal structures
The structures of HI-6Nsarin
nonaged-mAChE, HI-6Nsarin
aged-
mAChE, and K027NmAChE are generally very similar to that of
apo mAChE [20]. However, relative to the apo structure, a large
structural change of Trp286 is seen in HI-6Nsarin
nonaged-mAChE
and K027NmAChE; Trp286 is disordered in HI-6Nsarin
aged-
mAChE (see below); minor structural changes are also observed
for Tyr337 and Tyr341. Similar to other reported mAChE
structures [20–26], the loop region between residues 258–264 is
not visible in the electron density map; the loop region of residues
490–498, which is located distant from the catalytic site, is poorly
defined. For HI-6Nsarin
nonaged-mAChE residues 490–498 were
omitted at the end of the refinement. The K027NmAChE and HI-
6Nsarin
aged-mAChE structures contains 5 residues listed in outlier
regions of the Ramachandran plot (Table 1). The Protein Data
Bank (PDB) entry codes for HI-6Nsarin
nonaged-mAChE, HI-
Figure 1. Inhibition and aging of AChE exemplified by the nerve agent sarin (A) and reactivation of sarin-inhibited AChE by HI-6 (B).
doi:10.1371/journal.pone.0005957.g001
Structure of HI-6NSarin-AChE
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aged-mAChE, and K027NmAChE are 2WHP, 2WHQ, and
2WHR, respectively.
Crystal structure of HI-6Nsarin
nonaged-mAChE
Seven datasets were collected after pre-treatment of the mAChE
crystals with sarin for 30 minutes followed by 1-, 2-, 3-, 3-, 4-, 5-,
and 10-minute exposures of the sarin
nonaged-mAChE crystals to
HI-6, respectively. The structure from the dataset with 1-minute
exposure to HI-6 was determined to a resolution of 2.2 A ˚ (Table 1).
The structures from the remaining six datasets were refined by 20
cycles of rigid-body refinement followed by 20 cycles of restrained
refinement. In the electron density maps from the 2- and 3-minute
datasets, sarin is also well defined. However, the structures from
datasets with 2–10 minute exposures to HI-6 were not further
refined as they are not as good as the 1-minute dataset in terms of
the quality of the electron density that defines sarin. In the initial
electron density map from the 1-minute dataset, there is a high-
density feature corresponding to the phosphorus atom covalently
bound to the Ser203 hydroxyl oxygen atom. In the maps from
other datasets, the occupancy of the phosphorus atom decreases as
the exposure time increases, presumably due to the progress of
reactivation. Gratifyingly, the final electron density map from the
1-minute dataset is of good quality and clearly defines the sarin
conjugate including its isopropoxy chain (Figures 2A and B).
Similar to a previously determined structure of the sarin
nonaged-
conjugatedmAChE(sarin
nonaged-mAChE)[26],inHI-6Nsarin
nonaged-
mAChE, the –P=O oxygen atom is hydrogen-bonding to main-
chain nitrogen atoms of Gly121 (2.9 A ˚), Gly122 (2.7 A ˚) and Ala204
(2.8 A ˚), namely, the phosphonyl oxygen atom is anchored at the
oxyanion hole (Figures 2C and supporting information Figure S1);
the methyl group of sarin is accommodated in the acyl pocket
surrounded by aromatic rings of Trp236, Phe295, and Phe297; the
isopropoxyl group is aligned along the axis of the active-site gorge
with its oxygen atom hydrogen-bonding to a water molecule
(Wat169, 2.8 A ˚) and to the N
e atom of His447 (3.1 A ˚) that forms a
catalytic triad with Ser203 (the distance of N
e to O
c is 3.0 A ˚)a n d
Glu334 (the distance of N
d to O
e is 2.6 A ˚).
In the HI-6Nsarin
nonaged-mAChE structure, the carboxyamino-
pyridinium ring of HI-6 is sandwiched by cation-pi interactions
from side chains of Tyr124 and Trp286. The side chain of Trp286
undergoes a large conformational change relative to the apo
mAChE (Figure 2D and supporting information Figures S1 and
S2). On the surface of the protein, there is an electron density
located near the indole ring of Trp286. Modelling this density
feature as a carbonate ion resulted in good correlation to the
crystallographic data and this ligand was included in the final
model. The carboxyamino oxygen atom of HI-6 forms a hydrogen
bond to the main-chain nitrogen atom of Ser298 (2.9 A ˚), while the
carboxyamino nitrogen atom interacts with the side-chain of
Glu285 via a water-mediated hydrogen bond network (Wat35,
3.0 A ˚ to the nitrogen atom and 2.7 A ˚ to the carboxyl oxygen
atom). The electron density for the side chain of Asp74 is
disordered and thus modelled in two conformations: one is similar
to that found in the apo mAChE structure, and the other, which is
dominant, point with its carboxyl oxygen toward the central linker
of HI-6. This interpretation resulted in a residual positive density
in the vicinity of Asp74 that may account for a low-occupancy
position for the oxime moiety of HI-6 (Figure 2A), as shown by the
Table 1. Data Collection and Refinement Statistics.
Data collection HI-6Nsarin
nonaged-mAChE HI-6N sarin
aged-mAChE K027NmAChE K027PKNmAChE
PDB entry code 2WHP 2WHQ 2WHR –
Wavelength 1.041 1.041 1.131 0.919
Space group P212121 P212121 P212121 P212121
Unit cell 79.36112.26227.0 79.26112.36227.1 79.66112.36227.1 77.46110.76227.5
Resolution (A ˚) 29.8–2.2 (2.32–2.2) 29.2–2.2 (2.3–2.15) 19.8–2.6 (2.7–2.54) 29.3–3.2 (3.4–3.2)
Total no. of refl. 765502 (111128) 633429 (91067) 463807 (46633) 239669 (35230)
Unique refl. 102346 (14724) 110895 (16023) 64776 (8351) 33083 (4774)
Completeness 99.2 (98.9) 99.7 (99.9) 98.0 (87.7) 99.9 (100.0)
Multiplicity 7.5 (7.5) 5.7 (5.7) 7.2 (5.6) 3.8 (3.8)
Rmerge
1 0.065 (0.464) 0.065 (0.436) 0.055 (0.290) 0.105 (0.359)
Mean(I)/sd(I) 21.9 (5.1) 15.3 (4.5) 27.1 (7.2) 14.7 (6.2)
Refinement
R-factor
2/Rfree
3 0.180/0.210 0.190/0.210 0.170/0.220 –
RMS bonds (A ˚) 0.013 0.010 0.004 –
RMS angles (u) 1.40 1.20 0.90 –
Ramachandran plot
4%/no. of residues
Favored 98.1/1022 97.3/1026 96.3/1021 –
Allowed 1.9/20 2.2/23 3.2/34 –
Outlier 0/0 0.5/5
5 0.5/5
6 –
1Rmerge=(g|I – ,I.|)/gI, where I is the observed intensity and ,I. is the average intensity obtained after multiple observations of symmetry related reflections.
2R-factor=(g||Fo|–| Fc||)/g|Fo|, where Fo and Fc are observed and calculated structure factors, respectively.
3Rfree uses 2% randomly chosen reflections defined in Brunger [50].
4The Ramachandran plots were determined using the program Rampage [56].
5Residues listed as outliers are A Gly002, B Asp494, B Ser495, B Lys496, and B Ser497.
6Residues listed as outliers are A Gly342, B Gly342 , A Asp494, B Lys496, and B Ser497.
doi:10.1371/journal.pone.0005957.t001
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nonaged-
mAChE described below. The oxime-pyridinium ring of HI-6
enters the catalytic site and forms cation-pi interactions with side
chains of Tyr124, Tyr337, Phe338, and Tyr341. The two carbon
atoms of HI-6 that are near Tyr337 are not well defined by the
electron density map; these atoms clash with the side chain of
Tyr337 (3.1 A ˚) and have high B factors. These observations
suggest that the oxime-pyridinium ring is rather mobile (adopting
multiple conformations) in the active-site gorge. In addition, a
minor main-chain displacement for Tyr341 was observed, which is
presumably caused by unfavourable interactions between the
oxime-substituted pyridinium ring and the side chain of Tyr341.
Figure 2. The final electron density map of HI-6Nsarin
nonaged-mAChE (A and B) and close-up views for conjugation of sarin
nonaged (C)
and binding of HI-6 (D) to mAChE that is superimposed to the apo mAChE. Since the oxime O1, N1 and C1 atoms could not be
unambiguously defined, they are not included in the final structure. AChE, sarin, and HI-6 are shown in cyan, yellow and orange, respectively. Putative
hydrogen bonding interactions are shown with red dashed lines. In A and B, the 2|Fo|–| Fc| map is contoured at 1s (blue), and the |Fo|–| Fc| map is
contoured at 3.5s (green) and 23.5s (red). The apo mAChE is shown in grey (C and D). A cross-eyed stereo view of HI-6Nsarin
nonaged-mAChE is shown
in supporting information Figure S1 and an omit map is shown in supporting information Figure S2.
doi:10.1371/journal.pone.0005957.g002
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chain nitrogen of Phe295 (N
Phe295). The high-density feature
region is hereafter referred to as the Phe295 site. In a previously
determined structure of HI-6 in complex with the non-phospho-
nylated mAChE (HI-6NmAChE), the oxime oxygen atom was
modelled into the same density feature [24]. During the initial
refinement of the HI-6Nsarin
nonaged-mAChE complex, the oxime
group was modelled into the Phe295 site. However, the |Fo|–
|Fc| electron density map (contoured at 5s) showed a residual
positive difference electron density at the Phe295 site and poor
connectivity between the oxime oxygen atom and the pyridinium
ring. On the other hand, modelling a chloride at the Phe295 site
and placing the oxime group close to Asp74, showed no residual
positive or negative electron density in the Phe295 site, but the
oxime moiety shows a peak in the negative difference electron
density map and a steric clash between the oxime oxygen atom
and the beta carbon atom of Asp74. Furthermore, there is a weak
electron density that connects the oxime-pyridinium ring to the
side chain of Tyr341 in the B-monomer of the asymmetric unit,
possibly indicating that a small population of HI-6 has the oxime
moiety pointing toward the aromatic ring of Tyr341, as shown by
the microsecond molecular dynamics simulations described below.
Subsequent refinement of a model with the oxime moiety pointing
toward the side chain of Tyr341 resulted in a steric clash between
the oxime and the tyrosine side chain. To investigate whether a
halide occupies the Phe295 site, we collected three datasets for the
HI-6NBRNmAChE complex using a soaking buffer containing
50 mM HI-6 and 1 M KBr. This experiment was inspired by the
observation of a well-defined bromide, which is hydrogen bonding
to N
Phe295, in a supporting crystal structure of a non-phosphony-
lated mAChE in complex of K027 (see below). These datasets were
collected at wavelengths of 0.91905, 0.91944, and 1.80000 A ˚,
respectively, allowing identification of bromide and chloride [27].
However, analysis of anomalous difference Fourier maps calcu-
lated from these datasets did not show any occupancy of either
bromide or chloride (data not shown).
Because of no conclusive evidence for the identity of the
electron density feature at the Phe295 site, in the final model of the
HI-6Nsarin
nonaged-mAChE complex, we did not include the oxime
moiety and instead modelled a water molecule (Wat659) at the
Phe295 site. This interpretation resulted in a residual positive
electron density located between the Phe295 site and the oxime-
pyridinium ring (Figure 2A). This density feature may represent
the oxime moiety of a fraction of HI-6 with its oxime oxygen at a
distance of ,2.9 A ˚ away from N
Phe295 (data not shown). Residual
positive electron densities were also found in the vicinity Asp74
(Figure 2A). As supported by the microsecond molecular dynamics
simulations described below, these features may represent minor
populations of the oxime moiety. In addition, a low-occupancy
HI-6 binding site at the surface of the protein is implied by several
residual positive electron densities found close to the His287-
Ser293 loop region.
There is a residual positive electron density found at a location
that is above the indole ring of Trp86 and close to the nonaged
sarin (Figure 2A). An interpretation of this electron density as the
binding of HI-6 in the vicinity of Trp86 and the intact sarin is,
however, not supported by the distance of ,3.0 A ˚ between the
pyridinium-oxime ring of HI-6 and the sarin O-isopropyl chain
(see supporting information Figure S3). Such a short distance
would cause a severe steric clash. This interpretation is not
supported by the simulation described below either. Alternatively,
the electron density could suggest that a small fraction of the
reactivation product, phosphonylated HI-6, binds in the vicinity of
Trp86. However, we did not observe an increase of the residual
electron density in subsequent datasets with longer HI-6-exposure
times, while we observed that the occupancy of the phosphorus
atom decreases as the HI-6 exposure time increases. A satisfactory
interpretation of these observations is the binding of HI-6 in a
small fraction of an enzyme with an aged sarin as shown in the HI-
6Nsarin
aged-mAChE crystal structure described below. This inter-
pretation is supported by the observation of a negative electron
density (visible at a contour level of –4s, Figure 2A) close to the
phosphorus atom of the conjugate that is likely associated with a
small fraction of an aged enzyme. The loss of the isopropyl moiety
in a small fraction of the aged enzyme provides space and negative
charge to accommodate the cationic pyridinium-oxime ring in the
vicinity of Trp86 and the aged sarin, as supported by the
superposition of HI-6Nsarin
nonaged-mAChE to HI-6Nsarin
aged-
mAChE (see supporting information S3) The aging half-life for
sarin in mAChE is presumably close to that of sarin in hAChE
(,3 hours) [8], and we found that the half-life of sarin
nonaged-
mAChE in the presence of HI-6 is ,4.6 minutes. These half-life
values and the seven datasets with the HI-6-exposure times less
than 10 minutes explain why we observed only the change of the
electron density for the phosphorus atom in the sarin
nonaged-
mAChE in time, adding further support to the interpretation of the
residual electron density as the binding of HI-6 in a small fraction
of the sarin
aged-mAChE.
Crystal structure of HI-6Nsarin
aged-mAChE
To further support the interpretation of the residual electron
density found above the indole ring of Trp86 in HI-6Nsarin
nonaged-
mAChE, we investigated the binding of HI-6 in the corresponding
aged enzyme complex (HI-6Nsarin
aged-mAChE) by a crystal
structure analysis to a resolution of 2.2 A ˚ (Table 1). The
dealkylated form of sarin was explicitly resolved in the 2|Fo|–
|Fc| and |Fo|–| Fc| electron density maps (Figure 3A). The –
P=O oxygen atom forms hydrogen bonds to the main-chain
nitrogen atoms of Gly121 (2.7 A ˚), Gly122 (2.7 A ˚), and Ala204
(2.9 A ˚). The methyl carbon atom is accommodated in the acyl
pocket, close to the side chains of Trp236, Phe295 and Phe297.
The oxyanion of the aged sarin conjugate forms hydrogen bonds
with the N
e atom of His447 (2.7 A ˚) and with a water molecule
(Wat341, 2.9 A ˚).
A visible electron density feature spans the active-site gorge of
mAChE (Figure 3B). In contrast to the HI-6Nsarin
nonaged-mAChE
crystal structure, the oxime-pyridinium ring of HI-6 in the aged
enzyme is ordered whereas the carboxyamino-pyridinium portion
is disordered. The oxime-pyridinium ring is engaged in a parallel,
cation-pi interaction with the indole ring of Trp86 (Figure 3) and a
hydrogen bond between the oxime oxygen atom and the main-
chain oxygen atom of His447 (3.2 A ˚). A positive electron density
feature, most likely a low-occupancy water molecule (correspond-
ing to Wat752 in the apo mAChE crystal structure), was found close
to the oxime-pyridinium ring (Figures 3A and 3C). The electron
density map of Tyr337 is slightly disordered, suggesting that
Tyr337 adopts two side-chain conformations. One is similar to the
conformation found in the apo mAChE crystal structure and it is
termed apo conformation. The other has the side chain pushed
toward His447 by the oxime-pyridinium ring of HI-6. There is a
steric clash between the oxime-pyridinium ring and the side-chain
of Tyr337 in its apo conformation. There is an additional positive
electron density close to the phenolic oxygen atom of Tyr337 in its
apo conformation, which may account for a counter ion or an
alternative, low-occupancy HI-6 conformation with the oxime-
pyridinium ring parallel to Trp86. The remaining active-site gorge
contains 2|Fo|–| Fc| and |Fo|–| Fc| electron density features
that could not be unambiguously modelled (Figure 3B).
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5957The final model of HI-6Nsarin
aged-mAChE contains well-defined
atoms, namely, the aged sarin and the HI-6 oxime-pyridinium
parallel to Trp86. The carboxyamino-pyridinium ring of HI-6
bound above the indole ring of Trp86, HI-6 molecules bound
alternatively, and the side chain of Trp286 were omitted from the
final model. The occupancy of the oxime-pyridinium ring is set to
0.7 and the occupancies of the apo-like and HI-6-accommodating
side-chain conformations of Tyr337 are set to 0.3 and 0.7,
respectively in the final model.
Crystal structure of K027NmAChE
To investigate the identity of the electron density feature at the
Phe295 site in HI-6Nsarin
nonaged-mAChE, we determined the 2.6-A ˚
crystal structure of a non-phosphonylated mAChE in complex with
K027, a close analogue of HI-6 that is less effective in reactivating
the sarin
nonaged-hAChE than HI-6 (Tables 1 and 3). The key
structural difference between HI-6 and K027 is that the oxime
moiety is substituted at the 2-position of the pyridinium ring of HI-
6 and at the 4-position for K027. The para substitution prevents
Figure 3. The electron density map of HI-6Nsarin
aged-mAChE shown in blue and the positive difference map shown in green (A). The
omit map (contour level 3s) calculated after simulated annealing of a model in which HI-6 and the side chain of Trp286 were omitted (B). The
electron density map defining most atoms of the oxime-pyridinium ring of HI-6 (C). Alignment of HI-6Nsarin
aged-mAChE (cyan) to the apo mAChE
(grey) with putative hydrogen bonds shown with red dashed lines (D).
doi:10.1371/journal.pone.0005957.g003
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binds at the mAChE active site in a similar fashion as HI-6.
Indeed, similar to the binding of HI-6 in sarin
nonaged-mAChE
(Figure 4), in the K027NmAChE complex, the carboxyamino-
pyridinium ring of K027 is sandwiched by Tyr124 and Trp286,
and the 4-oxime-pyridinium ring enters the catalytic site where it is
found parallel to Tyr337 with its oxime oxygen forming a 2.9-A ˚
hydrogen bond to the main-chain oxygen of His447 and a 3.1-A ˚
hydrogen bond to a water molecule (Wat147). Interestingly, in
contrast to HI-6Nsarin
nonaged-mAChE, Asp74 adopts the side-chain
Figure 4. The final 2|Fo|–| Fc| electron density map of K027NmAChE shown in blue and the positive difference map shown in green
(A). The anomalous difference Fourier map (red) clearly indicating that a bromide ion occupies the Phe295N site (B). The binding of K027 (orange)
within the active-site gorge of mAChE (C and D). The oxygen and nitrogen atoms are shown in red and blue, respectively. Water molecules are shown
with red spheres. K027NmAChE and the apo mAChE are shown in cyan and grey, respectively. The 2|Fo|–| Fc|, |Fo|–| Fc|, and anomalous difference
Fourier maps are contoured at 1s,63.5s, and 10s, respectively.
doi:10.1371/journal.pone.0005957.g004
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water molecules (Wat626 and Wat628) seem to bridge the
interaction between K027 and Asp74.
There is also a high-density feature at the Phe295 site in the
K027NmAChE complex. Because K027 was added to the crystals in
the K027NHBrsaltform, and because the 4-substitutedoxime group
cannot access the Phe295 site, the spherical feature was initially
modelled as a bromide, resulting in good correlation to the
crystallographicdata. This interpretation is further supportedbythe
anomalous difference Fourier map calculated from dataset
K027PKNmAChE (Table 1) collected at a wavelength of
0.91944 A ˚, close to the bromide K-edge. The anomalous difference
Fourier map shows a strong signal, visible at a contour level of 18s,
at the Phe295 site (Figure 4B). Thus, in the final model of the
K027NmAChE complex, the Phe295 site is occupied by a bromide
ion (BR1) with a distance of 3.3 A ˚ to N
Phe295 and 3.2 A ˚ to a water
molecule (Wat541). The distance of BR1 to the nitrogen atoms of
the 4-oxime- and 4-carboxyamino-substituted pyridinium rings of
K027 are 4.6 and 4.1 A ˚, respectively (Figure 4). A positive residual
electron density suggests that an unidentified ion interacts with the
hydroxyl oxygen of the catalytic residue Ser203.
Apparent pKa of HI-6
The pKa value of HI-6 was reported to be 7.28 [16], which is
chemically counterintuitive because the pKa values of close
analogues pralidoxime, obidoxime, and 1,n-alkylene-bis-N,N’-2-
pyridiniumaldoxime (n=3–6) are 7.8–8.0 [15,17,28]. We accord-
ingly measured the apparent pKa value of HI-6 using proton
nuclear magnetic resonance (NMR) spectra and found that the
pKa value of HI-6 is 7.63 (supporting information Figure S4).
Microsecond molecular dynamics simulation of HI-
6Nsarin
nonaged-mAChE
Inspired by a number of reported molecular dynamics
simulations [29–32], we performed 100 10-ns-long molecular
dynamics simulations (each with 1.0-fs time step and different
initial velocities) using an HI-6Nsarin
nonaged-mAChE crystal struc-
ture, which was partially refined from the dataset with 1-minute
exposure to HI-6, as a starting structure. This study was carried
out to determine popular conformations of the oxime-pyridinium
ring of HI-6 that is disordered in the crystal structure. In the
starting structure, the oxime oxygen atom was protonated (in the
neutral form) according to its pKa of 7.63 and purposely placed
3.7 A ˚ and 7.2 A ˚ away from the phosphorus atom and from
N
Phe295, respectively, by rotating two torsions along -N-CH2-O-.
Otherwise, the starting structure was the same as the partially
refined crystal structure. There was no water molecule placed to
form a hydrogen bond to N
Phe295 in the starting structure. The
reason to perform 100 10-ns-long simulations instead of one 1.0-
ms-long simulation was twofold. First, we found that the sampling
of multiple short simulations is more efficient than the sampling of
a single long simulation using the same simulation protocol
described in the Method section. Second, we also found that a
large conformational change occurred to the Trp86-containing
helix after 50 ns of our simulations of HI-6Nsarin
nonaged-mAChE,
which could relate to the reported back door opening of the AChE
active site [33,34] or indicate an artefact of the simulation protocol
that has not been evaluated rigorously for simulations longer than
20 ns.
A total of 2,000 instantaneous structures collected at 50-ps
intervals during the last 1.0-ns period of the 100 simulations were
subjected to a first-round cluster analysis using the averagelinkage
algorithm (epsilon=2.0 A ˚ and RMS on alpha-carbon atoms) [35].
The instantaneous structures and an average of the instantaneous
structures are hereafter termed conformers and an average
conformer, respectively. This analysis identified six clusters of
conformers. The number of conformers in Clusters 1–6 is 40, 60,
1800, 60, 20, and 20, respectively. Visual inspection of the average
conformer of the third cluster revealed a very distorted loop
containing residues 74–78 implying the loop is highly mobile. This
loop is connected to a helix that is directly involved in crystal
packing. This loop is also in contact with HI-6 in the crystal
structure.
All 1800 conformers from the most populated cluster (Cluster 3)
of the first-round cluster analysis were subsequently subjected to a
second-round cluster analysis using the averagelinkage algorithm
(epsilon=1.5 A ˚ and RMS on all atoms of residues 74–78). This
analysis identified 49 clusters. The number of conformers in
Clusters 1–5 is 400, 335, 89, 188, and 146, respectively, while the
numbers of conformers in the remaining clusters are all less than
89. Interestingly, the average conformer (denoted as A2C, see
supporting information Dataset S1) of the most populated cluster
(Cluster 1) of the second-round cluster analysis is similar to the
final model of HI-6Nsarin
nonaged-mAChE including the loop
containing residues 74–78; the root mean square deviation
(RMSD) of all alpha-carbon atoms between the two is 1.24 A ˚.I t
is worth noting that no energy minimization was performed on
A2C. This large RMSD difference is, however, caused partly by
crystal packing [36,37] and partly by the uncertainties of residues
with high B factors. To minimize the difference caused by crystal
packing and high B factors, we propose to use the RMSD of alpha-
carbon atoms for residues that are not involved in crystal contact
and have B factors of alpha-carbon atoms lower than the average
alpha-carbon B factor. This proposed RMSD is hereafter termed
cool-and-free RMSD (C&F RMSD). Indeed, the C&F RMSD
between the final crystal structure and A2C is 0.56 A ˚, suggesting
that A2C can represent the final model of the crystal structure in
solution. In A2C, the oxime-pyridinium ring of HI-6 is contracted
by ,38%, as shown in Figure 5, while the carboxyamino-
pyridinium ring is not contracted at all, implying the oxime-
pyridinium portion is highly mobile or intrinsically disordered
Figure 5. The HI-6 conformations in A2C (yellow) and A3C
(green) showing the disordered and ordered oxime-pyridinium
rings in A2C and A3C, respectively.
doi:10.1371/journal.pone.0005957.g005
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intrinsically ordered. The HI-6 structure with a contracted
oxime-pyridinium ring and an uncontracted carboxyamino-
pyridinium ring is also observed in the average of all 100,000
conformers collected at 1-ps intervals during the last 1.0-ns period
of the 100 simulations. These observations support the above-
described interpretations of the electron density map of HI-
6Nsarin
nonaged-mAChE.
To determine popular conformations of the oxime-pyridinium
ring, all 400 conformers from the most populated cluster (Cluster
1) of the second-round cluster analysis were subjected to a third-
round cluster analysis using the averagelinkage algorithm
(epsilon=1.0 A ˚ and RMS on all atoms of HI-6). This analysis
identified 8 clusters. The number of conformers in Clusters 1–8 is
235, 81, 20, 20, 20, 2, 2, and 20, respectively. As shown in Figure 6,
no contraction of the oxime-pyridinium ring was observed in any
average conformer of the 8 clusters, noting that no energy
minimization was performed on these average conformers. The
populations of the 8 clusters and the corresponding HI-6
conformers explain why the oxime-pyridinium ring is contracted
but the carboxyamino-pyridinium ring is not in A2C. Further-
more, some HI-6 conformations with the oxime group pointing to
Asp74 and Tyr341 are consistent with the afore-mentioned
interpretation of the HI-6Nsarin
nonaged-mAChE crystal structure.
In contrast to the HI-6 conformation in the previously reported
HI-6NmAChE crystal structure [24], none of the 8 average
conformers of HI-6 shown in Figure 6 has the oxime oxygen
atom hydrogen bonding to N
Phe295.
Interestingly, the average conformer (denoted as A3C, see
supporting information Dataset S2) of the most populated cluster
(Cluster 1) of the third-round cluster analysis has an RMSD of
1.26 A ˚ relative to all alpha-carbon atoms of the final model of the
HI-6Nsarin
nonaged-mAChE crystal structure. The C&F RMSD
between the two structures is 0.55 A ˚, indicating that A3C is the
major composite conformer of A2C, or a major composite
conformer of the crystal structure in solution. In A3C, the oxime-
pyridinium portion is stationary as it is uncontracted (see Figure 5);
the oxime oxygen atom is 6.0 and 6.9 A ˚ away from N
Phe295 and
the phosphorus atom, respectively, although the corresponding
distances are 7.3 and 3.7 A ˚ in the starting structure of the
simulations.
To investigate whether there is a possible water molecule that
forms a hydrogen bond to N
Phe295 as suspected the early stage of
structural refinement, we visually inspected an instantaneous
conformer (denoted as I3Cr, see Figure 7A and supporting
information Dataset S3) that was identified to be the closest to
A3C by the third-round cluster analysis. Because water molecules
are highly contracted in the average conformer A3C, structural
information on water has to be obtained from instantaneous
structures. I3Cr has a C&F RMSD of 0.51 A ˚ relative to A3C and
it is therefore a major composite conformer of A3C. As shown in
Figure 7A, in I3Cr, the oxime oxygen atom is 6.2 and 6.5 A ˚ away
from N
Phe295 and the phosphorus atom, respectively; there is
indeed a water molecule hydrogen bonding to N
Phe295, but this
water molecule does not form a hydrogen bond or a hydrogen-
bond network to the oxime oxygen atom. Instead, the oxime
oxygen atom forms a water-mediated hydrogen-bond network to
the isopropoxyl oxygen atom. The water molecule is 4.7 A ˚ away
from the N
e atom of His447. In contrast to the apo mAChE
structure, His447 in I3Cr does not have a hydrogen bond to
Glu334 that is presumably pushed away by sarin and HI-6 (see
Figure 7C).
A distance analysis of the 1800 conformers from the most
populated cluster (Cluster 3) of the first-round cluster analysis
identified 14 (1%) instantaneous conformers with a distance of the
oxime oxygen atom to the phosphorus atom ranging from 5.0 to
5.5 A ˚. These conformers are similar to I3Cr and they are
composite conformers of A3C. These instantaneous conformers
reveal the trajectories of the oxime group moving toward the
phosphorus atom for reactivation. In one of these, which is
denoted as I3C (see Figure 7B and supporting information Dataset
S4) and has the shortest distance of 5.0 A ˚ between the oxime
oxygen atom and the phosphorus atom, the oxime oxygen atom
has a hydrogen-bond network to the N
e atom of His447, the
bridging water molecule has a hydrogen bond to the sarin
isopropoxyl oxygen atom, His447 has a hydrogen bond to Glu334,
the N
e atom is 3.1 A ˚ away from the O
c atom of Ser203, but there
is no hydrogen bond between N
e and O
c as both atoms are
deprotonated (see Figure 7B). Because I3C has a C&F RMSD of
0.90 A ˚ to the HI-6Nsarin
nonaged-mAChE crystal structure, this
instantaneous composite conformer is relevant to the HI-
6Nsarin
nonaged-mAChE crystal structure and sheds light on the
reactivation mechanism by HI-6 as will be discussed below.
Cross-checking the simulation using the diffraction data
To cross check the microsecond molecular dynamics simulation
of HI-6Nsarin
nonaged-mAChE, deviations for all alpha-carbon atoms
between an aligned conformer and the final model of the HI-
6Nsarin
nonaged-mAChE crystal structure (monomer A of the
asymmetric unit) were computed and plotted against B factors of
their corresponding alpha-carbon atoms (see Figure 8), wherein
only alpha-carbon atoms were used for aligning the two structures.
As apparent from Figure 8A, the alpha-carbon deviations of
average conformers A3C and A2C correlate well with B factors for
all residues except for residues 350–356 and 372–385 that are in
fact involved in crystal contact. The alpha-carbon deviations of
instantaneous conformers I3Cr and I3C also correlate reasonably
with B factors (Figure 8B). These correlations are confirmed by
C&F RMSDs of average conformers A3C (0.55 A ˚) and A2C
(0.56 A ˚) relative to the corresponding crystal structure and by the
corresponding C&F RMSDs of instantaneous conformers I3Cr
Figure 6. The HI-6 conformations in the average conformers of
all 8 clusters from the third-round cluster analysis (green:
cluster 1; cyan: cluster 2).
doi:10.1371/journal.pone.0005957.g006
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doi:10.1371/journal.pone.0005957.g007
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carbon atoms of the crystal structure. Horizontal axis: residue ID; vertical axis: alpha-carbon deviation in A ˚ and B factors scaled by 10% in A ˚2.
doi:10.1371/journal.pone.0005957.g008
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in accordance with the experimentally obtained diffraction data.
Biochemical characterization of HI-6 and K027
To obtain further support for the crystal structures described
above, we performed biochemical characterization of HI-6 and
K027 using mAChE and its mutants. Under the conditions used in
the soaking experiments (32% PEG 750 MME, 100 mM HEPES,
pH 7.0, 25 mM NaCl at 25uC), we found that the reaction rate
constant (kr) of HI-6 in reactivating the sarin
nonaged-mAChE is
,0.15 min
21 (tK of ,4.6 min), and the dissociation constant (KD)
of HI-6 for the sarin
nonaged-mAChE is ,100 mM. Analysis using a
partial mixed inhibition scheme showed that HI-6 has Ki values of
32 mM, 20 mM, and 255 mM for the wild-type non-phosphony-
lated mAChE and its Asp74Glu and Tyr341Ala mutants,
respectively (Tables 2 and supporting information Figure S5).
The Asp74Glu substitution resulted in a 1.6-fold increase in
affinity whereas the Tyr341Ala substitution decreased the affinity
by 8.2 fold. Under assay conditions similar to the reported ones
[8], the KD and kr values of K027 are 92 mM and 0.054 min
21 for
the sarin
nonaged-hAChE and 349 mM and 0.047 min
21 for the
DFP-hAChE, respectively (Tables 3 and supporting information
Figure S6). The 3.8-fold decrease in the affinity of K027 for the
DFP-hAChE compared to sarin
nonaged-hAChE suggests that the
binding of K027 involves the Phe295 site, because the reported
crystallographic studies showed that the DFP conjugation induces
a structural change of the Phe295-containing acyl loop (residues
287–299), whereas the sarin conjugation does not change the acyl
loop conformation found in the apo AChE [5,26,38].
Discussion
Support from known reactivation studies of AChE
mutants
The afore-described HI-6Nsarin
nonaged-mAChE structure deter-
mined by X-ray crystallography and multiple molecular dynamics
simulations (MMDSs) is consistent with reported reactivation
studies using HI-6 and conjugated AChEs that are comparable to
sarin
nonaged-mAChE [39–41]. For example, isopropyl-methyl-
phosphonothiocholine (iPrMP) reacts with AChE to yield the
same conjugate as sarin. Consistently, a Tyr124Glu mutation of
iPrMP-mAChE resulted in a 36-fold decrease of the bimolecular
reactivation rate constant for the reactivation by HI-6, and a 3-
fold reduction was also observed for the Trp286Ala substitution
[40]. The involvement of Tyr124 and Trp286 in the HI-6
reactivation is in agreement with our crystal structure and
simulations of HI-6Nsarin
nonaged-mAChE showing that the two
residues sandwiches the carboxyamino-pyridinium ring of HI-6
firmly through cation-pi interactions. In addition, the Tyr337Ala
mutant of mAChE reduces the bimolecular rate constant by 5.5-
fold and displays a 30-fold decrease in affinity [41], which is also
consistent with the hydrophobic interaction between Tyr337 and
HI-6 shown in the HI-6Nsarin
nonaged-mAChE crystal structure and
its simulated conformations. Other reported mutagenesis studies
suggest that the side chains of Phe295, Phe297, and Trp86 are less
critical for the reactivation of iPrMP-mAChE by HI-6 [39–41] as
substitutions of Phe295Leu, Phe297Ile, and Trp86Ala change the
bimolecular rate constant by 0.9- to 1.4-fold [40]. Again, the HI-
6Nsarin
nonaged-mAChE crystal structure (Figure 2A) and its
simulations (Figure 6) show no strong interactions between HI-6
and the side chains of these residues. The agreement between the
HI-6Nsarin
nonaged-mAChE structure and the mutagenesis studies
using either iPrMP or sarin described above offers a foundation for
the following discussion with regard to the enzymatic state.
The HI-6Nsarin
nonaged-mAChE complex at the Michaelis-
Menten state
In this article, we define the ground state that can directly
proceed to the transition state of the reactivation reaction as the
Michaelis-Menten state. An HI-6-bound mAChE conjugated to an
aged sarin or a non-phosphonylated mAChE in complex with HI-6
is not a complex at the Michaelis-Menten state (hereafter termed
Michaelis-Menten complex), as it cannot proceed to the transition
state. Unlike enzyme inhibitor design, one of the challenges of
enzyme reactivator design is the entrapment of a high-affinity
reactivator at the Michaelis-Menten state. While Michaelis-
Menten complexes can offer crucial information on how to avoid
the entrapment at the Michaelis-Menten state [19,42,43], such
Table 3. Reversible Inhibition (Ki), Dissociation (KD), and Reaction Rate Constants (kr). See supporting information Figure S6 for
details.
Oxime Ki (mM)
a hAChE KD (mM) hAChE kr (min
21) hAChE
Sarin DFP Ratio Sarin DFP Ratio
HI-6 35 50.1
b 1935
b 1.4/38.6 0.677
b 0.02
b 33.9
Obidoxime – 31.3
b 63.8
b 2.0 0.937
b 0.06
b 15.6
K027 – 92622
c 349647
c 3.8 0.05460.011
c 0.04760.003
c 1.1
aDetermined in this study (Table 2).
bData from [8].
cDetermined in this study, mean value6S.D. of 2–4 independent determinations.
doi:10.1371/journal.pone.0005957.t003
Table 2. Analysis of the Binding Constants of
Acetylthiocholine and HI-6 to AChE Using a Partial Mixed
Inhibition Scheme
3.
Construct K
1
m (mM) Ki
2 (mM) ab
hAChE 124643 5 631 . 2 60.1 0.260.0
mAChE 81663 1 621 . 9 60.2 0.160.0
Asp74Glu mAChE 182662 0 623 . 6 60.6 0.360.0
Tyr341Ala mAChE 119662 5 5 628 18610 0.860.2
1Mean value of 8 independent determinations6S.D.
2Mean value of at least 4 independent determinations6S.D.
3See supporting information Figure S5.
doi:10.1371/journal.pone.0005957.t002
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crystallographic studies. As reported recently [25] and discussed
below, some Michaelis-Menten complexes are obtainable now if
using crystallographic approaches that are complemented by
MMDSs or other means.
The reactivation of sarin
nonaged-mAChE by HI-6 is a relatively
efficient reaction with a rate constant of ,0.15 min
21 (tK of
,4.6 minutes) under the buffer condition that was used in the
crystallographic experiments. This discourages crystallographic
determination of the Michaelis-Menten complex because of two
competing requirements. First, the inevitable reactivation/aging
can significantly decrease the occupancy of the nonaged conjugate
if the HI-6-exposure time is around or longer than the half-lives of
sarin in the presence and absence of HI-6. Second, a short
exposure to the reactivator will limit the diffusion of the reactivator
into the enzyme and subsequently reduce the occupancy of the
reactivator. Accordingly, we used an HI-6 concentration that is at
least 100-fold higher than its KD (,100 mM) for HI-6Nsarin
nonaged-
mAChE to avoid the diffusion problem, and ran a time-course
experiment to find the shortest HI-6-exposure time that can
minimize the unwanted reactivation and aging and still yield a
good-quality electron density map. Knowing the aging half-life of
sarin of ,3 hours for hAChE [8] and the half-life of ,4.6 minutes
for sarin in the presence of HI-6, we found that 30-minute
exposure to 2 mM of sarin followed by one-minute exposure to
HI-6 led to a good-quality electron density map that unequivocally
defines a nonaged sarin and most of the HI-6 structure. We also
found that longer HI-6-exposure times successively decrease the
occupancy of the conjugate, whereas the occupancy of HI-6
remains unaffected (data not shown). The high concentration of
HI-6 in the soaking experiment could in theory lead to multiple
binding modes (i.e., HI-6 occupies low- and high-affinity sites). In
this study, we found that the high HI-6 concentration does not
interfere with the crystallographic determination of the HI-
6Nsarin
nonaged-mAChE structure, given the excellent correlation
of the crystallographic results to the microsecond molecular
dynamics simulation and the biochemical characterizations.
It was more challenging to determine the crystal structure of the
sarin
nonaged-mAChE in complex with HI-6 half of which is
intrinsically disordered, comparing to the Michaelis-Menten
complex of tabun-mAChE in complex with 1,7-heptylene-bis-
N,N9-2-pyridiniumaldoxime dichloride (ortho-7Ntabun-mAChE)
[25]. Without knowing the oxime-pyridinium portion of HI-6 is
highly mobile in the sarin
nonaged-mAChE active site, our initial and
exhaustive attempts to model the oxime moiety in the electron
density map were fruitless. The main problem of these attempts
was the interpretation of the density feature at the Phe295 site. On
the one hand, the following observations suggest that the oxime
oxygen atom occupies the Phe295 site with its oxime oxygen atom
hydrogen bonding to N
Phe295: (1) modelling the oxime group away
from the Phe295 site and close to Asp74 resulted in a negative
peak in the |Fo|–| Fc| map, a steric clash with the beta-carbon
atom of Asp74, and no 2|Fo|–| Fc| electron density of the oxime
moiety; (2) the Asp74Glu mutation moderately enhanced the
affinity of HI-6 for mAChE; (3) modelling the oxime group away
from the Phe295 site leaning toward Tyr341 resulted in a steric
clash with the side chain of Tyr341, but the side chain of Tyr341
shows no obvious signs of large-scale compensatory structural
changes; (4) the Tyr341Ala mutation decreased the affinity of HI-6
for the enzyme; (5) reactivation kinetics data of sarin- and DFP-
inhibited AChE indicate that HI-6 is more sensitive to the
conformational change of the Phe295 site than K027 (Table 3).
On the other hand, the initial modelling of the oxime group at the
Phe295 site resulted in residual positive difference electron density
at the Phe295 site and poor connectivity between the oxime
oxygen atom and the pyridinium ring. The disagreement was later
reconciled by our microsecond-scale MMDSs of HI-6Nsarin
nonaged-
mAChE that revealed the following structural and dynamic details.
First, the MMDSs did not show that the oxime group occupies
the Phe295 site with its oxime oxygen atom hydrogen bonding to
N
Phe295. A distance analysis of all 2,000 conformers collected at
50-ps intervals during the last 1.0-ns period of the 100 simulations
identified 60 conformers with a hydrogen bond between the oxime
oxygen atom and N
Phe295. This result precludes the concern that
the microsecond-scale simulation is perhaps still not long enough
to capture the conformations with the hydrogen bond to N
Phe295.
However, according to visual inspection, the main-chain confor-
mations of these unpopular conformers are markedly different
from that of the HI-6Nsarin
nonaged-mAChE crystal structure.
Instead of hydrogen bonding to the oxime oxygen atom, N
Phe295
has a hydrogen bond to a water molecule in both I3C and I3Cr
derived from the MMDSs, although there is no water molecule
that forms a hydrogen bond to N
Phe295 in the starting structure of
the simulation. The simulation result is consistent with other
AChE crystal structures that reveal a hydrogen bond between a
water molecule and N
Phe295 [20,25,44], it is also consistent with re-
inspection of our previously reported electron density map of
obidoxime-mAChE that identified a well-defined water molecule
at the Phe295 site [24]. Taken together, the MMDSs do not
support the interpretation of the observed electron density map of
HI-6Nsarin
nonaged-mAChE by modelling of the oxime group of HI-
6 at the Phe295 site that resulted in a poor connectivity between
the oxime oxygen atom and the pyridinium ring.
Second, the MMDSs showed that the oxime-pyridinium portion
of HI-6 is highly mobile and HI-6 adopts 8 major conformations
in the sarin
nonaged-mAChE active site (Figure 6). Some of the 8
conformations have the oxime group pointing to Asp74 and
Tyr341, whereas the most populated conformation has the oxime
group away from Asp74 and Tyr341. The former explains why
there is a weak electron density feature that connects the oxime-
pyridinium ring to the side chain of Asp74 or Tyr341; the latter
explains the above-described observations 1–5 that initially led to
the speculation that the oxime group occupies the Phe295 site.
Third, as to average conformers of A2C and A3C and
instantaneous conformers I3Cr and I3C derived from the
MMDSs, the C&F RMSDs relative to the crystal structure of
HI-6Nsarin
nonaged-mAChE are 0.56 A ˚, 0.55 A ˚, 0.67 A ˚, and 0.90 A ˚,
respectively. These results indicate that all four conformers have
the integrity of the crystal structure.
The 1-minute dataset likely contains structural information
more complex than the information we obtained through
crystallographic analysis and MMDSs using simplified structural
models. For example, as described above, the 1-minute crystal
contains a small fraction of the aged sarin conjugate in addition to
the dominating nonaged conjugate. Nonetheless, the consistency
among the diffraction data, the reactivation kinetics data, and the
MMDS results suggests that the HI-6Nsarin
nonaged-mAChE crystal
structure and the average conformer A3C represent the main
structure in the 1-minute crystal and in solution, respectively. It
also suggests that the HI-6Nsarin
nonaged-mAChE crystal structure
supplemented with I3C is a plausible Michaelis-Menten complex
that offers insights into reactivation mechanism and reactivator
design as discussed below.
Insight into the reactivation mechanism of HI-6
Given the HI-6Nsarin
nonaged-mAChE crystal structure and the
I3C model, a reactivation mechanism of HI-6 can now be
proposed at the atomic level (Figure 9). In I3C at the Michaelis-
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bond network to His447, the bridging water molecule and His447
have hydrogen bonds to the sarin isopropyl ether oxygen atom and
Glu334, respectively. This structural arrangement positions the
oxime oxygen atom 5.0 A ˚ away from the sarin phosphorus atom
before reaching the transition state (Figure 7B). There is a
hydrogen-bond network of Glu334-His447-Wat-Oxime (termed
the catalytic tetrad, Figure 9), which is akin to the hydrogen-bond
network of the catalytic triad (Glu334-His447-Ser203). In the
same way as the triad deprotonates the hydroxyl group of Ser203,
the tetrad deprotonates the oxime hydroxyl group and makes the
oxime a strong nucleophile for attacking the phosphorus atom that
is 5.0 A ˚ away from the oxime oxygen atom (Figure 9). It is worth
noting that about 19% (,37%) of the HI-6 oxime is ionized in
solution at the experimental pH of 7.0 (physiological pH of 7.4)
according to the pKa value of 7.63 for HI-6. However, the
negatively charged oximate is not complementary to the AChE
active site that has two anionic residues and 14 aromatic residues
with pi-electrons. The pKa of the oxime in this environment is
presumably higher than in water. Only the neutral oxime gets into
the active site and therefore AChE serves as a ‘‘buffer’’ that makes
100% of the oxime protonated. A tetrad is therefore needed to
deprotonate the oxime hydrogen to increase the intrinsic
nucleophilicity of HI-6. In addition to being a general base, the
tetrad also assists in alignment of the oximate for attacking the OP
moiety. Upon deprotonation, the oximate (RC=NO
-) becomes
less bulky than the neutral oxime (RC=NOH) and able to attack
the phosphorus atom through a vacated narrow space that is in
line with the O–P bond of Ser203 as shown in Figure 9 to form a
pentavalent, trigonal bipyramidal structure at the transition state
[5,45]. The –P=O oxygen atom of the transition-state structure
conceivably becomes an oxyanion that is stabilized by hydrogen
bonds from Gly121, Gly122, and Ala204. At the transition state
(Figure 9), the O
c atom of Ser203 presumably forms a hydrogen
bond with the imidazole proton as the distance between N
e and
O
c is 3.1 A ˚ in I3C. Finally at the product state, the oxyanion
pushes the O
c atom away to form a phosphonylated oxime and a
reactivated AChE (Figure 9).
The reactivation mechanism of HI-6 proposed herein is
consistent with a reactivation mechanism of ortho-7 conceivable
from our previously reported ortho-7Ntabun-mAChE crystal
structure, wherein the oxime oxygen atom is 3.4-A ˚ away from
the His447 N
e atom implying the ability to form a hydrogen bond
between the two atoms [25]. According to the pKa values of HI-6
and 1,6-hexylene-bis-N,N’-2-pyridiniumaldoxime described above,
both HI-6Nsarin
nonaged-mAChE and ortho-7Ntabun-mAChE struc-
tures suggest that the oxime group is protonated in the active site
before reactivation and that the catalytic tetrad for HI-6 (Glu334-
His447-H2O-Oxime) and the triad for ortho-7 (Glu334-His447-
Oxime) serve as an effective base that deprotonates the oxime
hydroxyl group to make it more nucleophilic to dephosphonylate
the conjugated AChE than the catalytic serine residue to
dephosphonylate the conjugated oxime. The structures disclosed
herein and our previously reported ortho-7Ntabun-mAChE struc-
ture provide, for the first time, plausible answers to long-standing
questions with regard to (1) whether the oxime group is
deprotonated or not in the AChE active site and (2) which
active-site residue serves as a base to deprotonate the oxime group
required for reactivation if the oxime is protonated. Furthermore,
the HI-6Nsarin
nonaged-mAChE structure provides insights into
reactivator design as discussed below.
Insights into improved reactivator design
In I3Cr, the oxime oxygen atom is 6.5-A ˚ away from the sarin
phosphorus atom, and it does not form a hydrogen bond or a
hydrogen-bond network to His447 (Figure 7A). In I3C, the same
oxygen is 5.0-A ˚ away and has a hydrogen-bond network to His447
(Figure 7B). Of 2,000 conformers collected at 50-ps intervals
during the last 1.0-ns period of the 100 simulations, 235 (12%) and
14 (1%) conformers adopt the I3Cr- and I3C-like conformations,
respectively. These percentages suggest that HI-6 converts from
I3Cr to I3C at an approximate ratio of 12 to 1. Apparently, there
is a significant energy barrier for the conversion from I3Cr to I3C
or a significant potential energy difference between I3Cr and I3C,
in addition to the energy barrier for changing from the Michaelis-
Menten state to the transition state. The energy barrier or
difference in potential energy between I3C and I3Cr likely limits
the ability of HI-6 to reactivate sarin
nonaged-mAChE, which
probably makes the HI-6Nsarin
nonaged-mAChE crystal structure
technically feasible. An important insight from this is to minimize
the barrier or potential difference by modifying the chemical
structure of HI-6. We previously reported an example of
improving catalysis by reducing one energy barrier to the
transition state [19,42], which led to the development of a
butyrylcholinesterase mutant as an effective cocaine hydrolase
with clinical potential for treating cocaine overdose [43]. Herein
we suggest that this type of modification offers a new venue to
improved HI-6, although it may not be directly applicable to other
conjugated AChEs.
Structural difference between HI-6 in complex with
conjugated and non-conjugated AChEs
In the HI-6Nsarin
nonaged-mAChE crystal structure aligned with
the previously reported HI-6NmAChE crystal structure [24], the
two proteins including all active-site residues except for Asp74 are
nearly identical, and the carboxyamino-pyridinium portions of HI-
6 in the two aligned complexes are almost the same as well. A
marked difference between the two HI-6 molecules is at the
oxime-pyridinium ring. The oxime oxygen atom has a hydrogen
bond to N
Phe295 in HI-6NmAChE, but it has no hydrogen bond or
Figure 9. Proposed reactivation mechanism of sarin
nonaged-mAChE by HI-6. Dashed lines represent the bond between the phosphorous
atom and the attacking or leaving atom. Hashed lines show hydrogen bonds.
doi:10.1371/journal.pone.0005957.g009
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Phe295 in HI-6Nsarin
nonaged-mAChE.
In the two aligned complexes, the distance from the oxime oxygen
atom of HI-6NmAChE to the phosphorus atom of HI-6Nsarin
no-
naged-mAChE is 8.7 A ˚, while the corresponding distances in I3C
and I3Cr are 5.0 and 6.5 A ˚, respectively. Consequently, no
plausible reactivation mechanism could ever be drawn from the
HI-6NmAChE structure, even with a sarin modeled into mAChE
with the phosphorus atom 8.7-A ˚ away from the oxime oxygen
atom.
Furthermore, the difference between conjugated and non-
conjugated AChE complexes suggests that caution should be used
when extrapolating mechanistic information from the non-
conjugated enzyme structure in the following examples. Visual
inspection of the HI-6NmAChE crystal structure could lead to a
hypothesis that the oxime group is deprotonated at the AChE
active site before reactivation as there is no nearby residue that can
deprotonate the oxime group. The pre-deprotonated oxime
hypothesis is however unlikely given (1) that the pKa value of
HI-6 is 7.63, and (2) that effective reactivation requires higher
nucleophilicity of a reactivator than that of the catalytic serine
residue. In addition, the HI-6NmAChE structure could suggest that
the hydrogen bond of HI-6 to N
Phe295 hampers the conversion of
HI-6 to the transition state thus reducing the reactivation
efficiency. However, simulations presented herein shows that the
oxime group does not form a hydrogen bond or a hydrogen-bond
network to N
Phe295 in the conjugated mAChE. Likewise, although
the oxime-pyridinium of K027 has a bromide-mediated hydrogen
bond to N
Phe295 in the K027NmAChE crystal structure, it is
premature to speculate that this hydrogen bond plays a role in
reactivation efficiency or actually contributes to the lower potency
of K027 than that of HI-6. This is because the hydrogen bond to
N
Phe295 could be absent in K027Nsarin
nonaged-mAChE based on the
information garnered from this study. In the same vein, without
the K027Nsarin
nonaged-mAChE structure, it is premature to assume
that the bromide anion found at the Phe295 site entraps K027
even though the bromide has strong ionic interactions with the two
cationic pyridinium rings.
Conclusions
Despite the challenges in determining structures of intrinsically
disordered reactivators in complex with enzymes possessing
conjugates that are vulnerable to the reactivators and at the same
time prone to develop resistance to reactivation, we have
determined the HI-6Nsarin
nonaged-mAChE crystal structure and
its computer model at the Michaelis-Menten state by combining
crystallography and microsecond molecular dynamics simulation.
In the HI-6Nsarin
nonaged-mAChE crystal structure, the carboxya-
mino-pyridinium portion of HI-6 is sandwiched by Tyr124 and
Trp286, while the oxime-pyridinium portion is highly mobile and
disordered. In the corresponding computed model (I3C) at the
Michaelis-Menten state that was identified from the microsecond-
scale MMDSs, the mobile oxime group forms a hydrogen-bond
network to His447 with the oxime oxygen 5.0-A ˚ away from the
nonaged sarin phosphorus atom. Our studies suggest a reactiva-
tion mechanism of sarin
nonaged-mAChE by HI-6 that is outlined as
follows: (1) upon binding HI-6 adopts a populated conformation
(I3Cr) and then converts to a less populated conformation (I3C)
whose oxime oxygen atom has a hydrogen-bond network to
His447 that simultaneously forms a hydrogen bond with Glu334
resulting in a tetrad of Glu334-His447-H2O-Oxime; (2) this tetrad
not only positions the oxime oxygen atom 5.0-A ˚ away from the
sarin phosphorus atom but also deprotonates the oxime hydroxyl
group; (3) upon deprotonation the oxyanion is less bulky and able
to attack the phosphorus atom to form a pentavalent, trigonal
bipyramidal structure at the transition state; (4) ejecting the O
c
atom of the catalytic Ser203 leading to the formation of a
phosphonylated oxime and a reactivated AChE. Our studies also
suggest that there is a significant energy barrier or potential energy
difference between I3C and I3Cr. Structural modification of HI-6
to reduce the barrier/difference could lead to improved
reactivators for sarin-conjugated mammalian AChEs.
Materials and Methods
Sarin belongs to Schedule 1 Chemicals as defined in the
Chemical Weapons Convention. Handling sarin requires suitable
personal protection, training, and facilities, and is regulated by the
Convention.
Materials
Sarin was synthesized according to a reported method [46]. HI-
6 and K027 were obtained from Drs. John Clement (Defense
Research Establishment, Canada) and Kamil Kuca (University of
Defence, Czech Republic), respectively.
Cloning, expression, crystal screening, and generation of
mAChE complexes
Cloning, expression, purification, and crystal screening of
mAChE were performed as previously described [23]. A soaking
solution (OX-buffer) containing HI-6 was prepared by dissolving
approximately 10–20 mg of HI-6 into 500 mL X-buffer, which was
composed of 28% (v/v) polyethylene glycol 750 monomethylether,
100 mM HEPES at a pH of 7.0, so that the concentration of HI-6
was much higher than the KD of HI-6 for sarin
nonaged-mAChE.
The stock solution was stored in liquid nitrogen and subsequently
used for all soaking and control experiments. Crystals were first
allowed to equilibrate slowly in X-buffer at 20uC. The X-buffer
supplemented with 2 mM sarin was then added to the equilibrated
crystals in ,10 portions of 1 mL during a period of 5 minutes.
Following inhibition of mAChE by sarin for 30 minutes, crystals
were transferred to 2–4 mL of OX-buffer and incubated during a
time ranging from one to ten minutes. The complex containing an
aged form of sarin was generated in a similar fashion, with the
exception that the crystal was incubated for 60 hours at 20uC,
prior soaking with OX-buffer. As a reference, the aging half-life of
sarin
nonaged-AChE is ,3 hours for the human enzyme at 37uC [8].
The HI-6NBRNmAChE complex was prepared by incubating a
crystal of mAChE in X-buffer supplemented with 50 mM HI-6
and 1 M KBr for ,30 minutes. The non-phosphonylated mAChE
complex with K027 was generated as previously described for
mAChENoxime complexes [24]. All soakings were terminated by
flash freezing of the crystal in liquid nitrogen.
Collection, processing, and refinement of diffraction data
X-ray diffraction data were collected at the MAXlab synchro-
tron (Lund, Sweden), beam lines I911-2, I911-3 and I911-5 on
MAR Research CCD detectors. Images were collected with an
oscillation angle of 1.0u per exposure and the total oscillation
range covered at least 140u per dataset. Intensity data were
indexed and integrated with XDS [47] and scaled using Scala
[48]. Seven datasets (soaking HI-6 for 1, 2, 3, 3, 4, 5, and 10
minutes) were collected for HI-6Nsarin
nonaged-mAChE, four
datasets were collected for K027NmAChE, and three datasets were
collected for HI-6NBRNmAChE. Anomalous data were collected
after fluorescence scans around the bromide K-edge. The HI-
6Nsarin
nonaged-mAChE structure obtained from the crystal with
one-minute incubation with HI-6 was determined using rigid-body
refinement with a modified apo structure of mAChE (PDB entry
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Trp286, and all small-molecule ligands were removed from the
starting model. Further crystallographic refinement was carried
out using restrained–isotropic–B-factor refinement as implement-
ed in the program Refmac5 [49]. The refinement included 98% of
the data while the remaining 2% was used to follow the progress of
the refinement with R-free [50]. The R-free dataset was obtained
from a previously determined structure (PDB entry code: 2GYU
[23]) and was used for all datasets. Several rounds of refinement
were performed, alternating with manual rebuilding of the model
after visualization of 2|Fo|–| Fc| and |Fo|–| Fc| maps using
programs O [51] and COOT [52]. Towards the end of the
refinement, TLS refinement as implemented in phenix.refine was
used [53]. Water molecules were added using COOT, phenix.re-
fine and by manual model building using the 2|Fo|–| Fc| and
|Fo|–| Fc| maps contoured at 1s and 3.5s, respectively. The
remaining six datasets of HI-6Nsarin
nonaged-mAChE were partly
refined by 20 cycles of rigid-body refinement and 20 cycles of
restrained–isotropic–B-factor refinement using the modified apo
mAChE structure as a starting model. The structures of HI-
6Nsarin
aged-mAChE and K027NmAChE were determined and
refined using the same approach as described for HI-6Nsarin
no-
naged-mAChE. The angles and bonds for atoms bound to the
phosphorous atom were determined using the Spartan program
(Wavefunction Inc.) and the Hartree-Fock method with the 6-
31G* basis set. The quality of the final models was evaluated using
PROCHECK, WHATCHECK, and Rampage [54–56]. Figures
were made using the PyMol program [57]. Atom ID definitions
are shown in supporting information Figure S7.
Site-directed mutagenesis
Recombinant ‘‘wild-type’’ mAChE was used as a template for
site-directed mutagenesis introduced using the QuikChange II
Site-Directed Mutagenesis Kit (Stratagene). All DNA sequences
were verified by sequencing carried out at MWG Biotech
(Germany). HEK-293F cells (Invitrogene) were maintained in
Dulbecco’s DMEM medium supplemented with 10% fetal calf
serum and appropriate antibiotics. Cells (3610
6/100 mm plate)
were transfected with 25 mg DNA-calcium phosphate co-precip-
itate (Invitrogene). After 24 hours, cells were washed and
incubated with fresh media for additional 48 hours. Transfected
clones were selected by incubation with media containing
Geneticin (Invitrogene) at a concentration of 0.5 mg/mL until
cell death subsided. Pools of stable clones were transferred to
Dulbecco’s DMEM medium supplemented with 2% fetal calf
serum and the secreted mAChE mutant was collected in the
supernatant.
Determination of the Michaelis-Menten parameters of
mAChE mutants
Enzyme activities of the secreted mAChE mutants described
above were measured spectrophotometrically using a procedure
based on the method developed by Ellman and co-workers [58].
This form of enzyme has the same catalytic parameters as the
chromatographically purified enzyme used for crystallography
according to our comparative kinetics studies. Acetylthiocholine
iodide was used as a synthetic substrate that was hydrolyzed to
produce thiocholine that in turn reacted with a 5,59-dithiobis(2-
nitrobenzoic acid) to yield a product measurable spectrophoto-
metrically at 412 nm. To calculate the Michaelis-Menten constant
(KM), 0.2 mM 5,59-dithiobis(2-nitrobenzoic acid), 0.1 M phos-
phate buffer at pH of 8.0, and protein were mixed and the reaction
was started by adding different concentrations of acetylthiocholine
iodide and measured during 1 min in a BioTek Powerwave plate
reader (yielding 8 replicates). All assays were performed at 30uC.
The data were analyzed using the Enzyme Kinetics module of the
program SigmaPlot 9.0.
Determination of inhibition constants for oximeNmAChE
complexes
Inhibition constants of oximeNmAChE complexes were obtained
from the apparent Michaelis-Menten constant (KM
app) and the
apparent maximal velocity (V
app) in the presence of HI-6 at various
concentrations. The KM
app and V
app values were determined using
the Enzyme Kinetics module of SigmaPlot 9.0. The mode of
inhibition was determined by analysis of Lineweaver-Burke plots
using the statistical module of SigmaPlot. The best-fit results were
obtained by using a mixed partial inhibition model (see supporting
information Figure S5). At least four replicates were measured for
each HI-6 concentration.
Reactivation kinetics
Reactivation kinetics was investigated using the reported discon-
tinuous method [8]. To investigate the reactivation rate under the
buffer condition that was similar to the one used during crystal
soaking, the sarin
nonaged-mAChE was incubated with HI-6 at various
concentrations (20–300 mM) in a buffer composed of 32% PEG 750
MME, 100 mM HEPES at pH of 7.0, 25 mM NaCl, at 25uC. After
3, 6, 9, 12, and 15 minutes, samples were withdrawn and the activity
was measured as described above. Secondary plots of kobs versus the
concentration of HI-6 (supporting information Figure S6) were used
to determine the affinity between HI-6 and the phosphonylated
enzyme (KD)a n dt h er a t ec o n s t a n tf o rt h ed i s p l a c e m e n to ft h e
phosphorous conjugate (kr). The reactivation of diisopropyl fluoro-
phosphate- (DFP-) or sarin-inhibited recombinant human AChE
(hAChE) by K027 was measured using a reported buffer condition
[8]. The use of hAChE was for comparison with literature data. The
concentrations of K027 used in the reactivation of the sarin
nonaged-
inhibited hAChE and the DFP-inhibited hAChE were 0.1–75 mM
and 25–3000 mM, respectively.
Determination of the apparent pKa of HI-6
The apparent pKa of HI-6 was determined by the
1H NMR
chemical shift change of protons of HI-6 specified in supporting
information Figure S4 as a function of solution pH. Thus,
1H
NMR spectra of 13 solutions with 20 mM HI-6 and 200 mM
phosphate buffer in D2O at pH of 5.58–9.86 were recorded.
Proton chemical shifts were referenced to internal 3-(trimethylsi-
lyl)propionic acid(d4). The apparent pKa of HI-6 was obtained by
non-linear least squares fit of the observed chemical shifts to
Equation 1 by applying the Levenberg-Marquardt method.
Parameters dHA, dA, and pKa were defined as adjustable.
dobs ~ dHA zdA 10pH-pKa  
1z10pH-pKa 
ð1Þ
where dobs is the observed
1H NMR chemical shift at a defined
pH,dHA is the limiting
1H NMR chemical shift of the acid form
and dA is the limiting
1H NMR chemical shift of the anionic form.
Microsecond molecular dynamics simulations
MMDSs were performed by using the PMEMD module of
AMBER 8.0 [59] with the AMBER force field (frcmod.ff99) [60].
The topology and coordinate files were generated by the PREP,
LINK, EDIT, and PARM modules of AMBER 5.0 [61]. All
simulations used (1) a dielectric constant of 1.0, (2) the Berendsen
coupling algorithm [62], (3) a periodic boundary condition at a
constant temperature of 300 K and a constant pressure of 1 atm
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method to calculate long-range electrostatic interactions [63], (5) a
time step of 1.0 fs, (6) the SHAKE-bond-length constraints applied
to all the bonds involving the H atom, (7) saving the image closest
to the middle of the ‘‘primary box’’ to the restart and trajectory
files, (8) formatted restart file, and (9) default values of all other
inputs of the PMEMD module.
The atomic charges of the sarin
nonaged-conjugated serine residue
and HI-6 with a protonated oxime group instead of an oxime
anion were obtained according to the RESP procedure [64] with
ab initio calculations at the HF/6-31G*//HF/6-31G* level using
Gaussian98 [65]. The starting structure of HI-6Nsarin
nonaged-
mAChE was taken and modified from an early crystal structure
that was partially refined from the dataset with 1-minute exposure
to HI-6. This crystal structure contains residues 493–496 (which
were omitted in the final crystal structure) and has the oxime
oxygen atom modeled to form a hydrogen bond to the main-chain
nitrogen atom of Phe295 (N
Phe295). The modification was to rotate
torsions along -N-CH2-O- of HI-6 in order to place the oxime
oxygen atom 3.7 A ˚ and 7.2 A ˚ away from the phosphorus atom
and from N
Phe295, respectively. This modification was for
investigating the oxime hydrogen bond to N
Phe295. For mAChE,
His447 was treated as HID; His223 and His387 were treated as
HIE; all other His residues were treated as HIP. A total of 54
crystallographically determined water molecules (named HOH)
that were located inside the enzyme were included in the mAChE
structure for simulations.
The water-containing HI-6Nsarin
nonaged-mAChE complex was
refined by energy minimization using a dielectric constant of 1.0
and 100 cycles of steepest-descent minimization followed by 100
cycles of conjugate-gradient minimization. The resulting complex
was solvated with 16,929 TIP3P water molecules (named WAT)
[66], leading to a system of 59,265 atoms. The WAT molecules
were obtained from solvating the complex using a pre-equilibrated
box of 216,000 TIP3P molecules, whose hydrogen atom charge was
set to 0.4170, where any water molecule was removed if it had an
oxygen atom closer than 2.2 A ˚ to any solute atom or a hydrogen
atom closer than 2.0 A ˚ to any solute atom, or if it was located
further than 8.2 A ˚ along the x-, y-, or z-axis from any solute atom.
The solvated complex system were energy-minimized for 100
cycles of steepest-descent minimization followed by 100 cycles of
conjugate-gradient minimization to remove close van der Waals
contacts in the system, then heated from 0 to 300 K at a rate of 10
K/ps under constant temperature and volume, and finally
simulated at 300 K under constant temperature and pressure.
One hundred 10-ns-long simulations were carried out on 200
Apple Xservers each equipped with two G5 processors at a clock
rate of 2.0/2.3 GHz, and each of these simulations used a unique
seed number for initial velocities.
Average structures were obtained by using the CARNAL
module of AMBER 5.0. Cluster analyses were performed by using
the PTRAJ module [35] of AMBER 10. RMSDs were calculated
by using the McLachlan algorithm [67] as implemented in ProFit
V2.6 (http://www.bioinf.org.uk/software/profit/). The C&F
RMSDs were obtained by (1) generating symmetry mates within
12 A ˚ using PyMol 0.99rc6, (2) identifying not-free residues that
have a distance of ,8.0 A ˚ between any non-hydrogen atom of the
structure in the primary cell and any non-hydrogen atom of the
symmetry mates, (3) identifying hot residues that have alpha-
carbon atoms with B factors greater than the average alpha-
carbon B factor, (4) identifying short peptides with up to four
residues that are between two hot residues, two not-free residues,
or between a hot and a not-free residue, (5) deleting the hot and
not-free residues and the short peptides from the crystal structure
and from the structure to be compared, and (6) computing the
alpha-carbon RMSD of the truncated proteins using ProFit. The
coordinates of four MMDS-generated structures are provided in
supporting information Datasets S1, S2, S3 and S4.
Supporting Information
Figure S1 Cross-eyed stereo view of HI-6Nsarin
nonaged-mAChE.
Found at: doi:10.1371/journal.pone.0005957.s001 (3.99 MB TIF)
Figure S2 Omit electron density map covering HI-6Nsarin
nonaged-
mAChE, calculated after simulated annealing of a model in which
HI-6, Asp74, sarin
nonaged-Ser203, and Trp286 were omitted. The
|Fo|-| Fc| map is contoured at 3s (green) and -3s (red).
Found at: doi:10.1371/journal.pone.0005957.s002 (7.30 MB TIF)
Figure S3 Superposition of HI-6Nsarin
nonaged-mAChE (yellow)
and HI-6Nsarin
aged-mAChE (green) with the |Fo|-| Fc| electron
density map of HI-6Nsarin
nonaged-mAChE contoured at 3s.
Found at: doi:10.1371/journal.pone.0005957.s003 (4.12 MB
DOC)
Figure S4
1H NMR chemical shift of proton b versus pH from
experiment and regression model.
Found at: doi:10.1371/journal.pone.0005957.s004 (1.02 MB TIF)
Figure S5 Hydrolysis of acetylthiocholine by wild-type mAChE
in the presence of different concentrations of HI-6 (A) and the
resulting Lineweaver-Burke plot (B). The partial mixed inhibition
model employed for the analysis of HI-6 binding to mAChE
substitutions (C). Letters E, S, P, and I designate the free enzyme,
the substrate, the product, and the inhibitor HI-6, respectively.
Found at: doi:10.1371/journal.pone.0005957.s005 (0.84 MB TIF)
Figure S6 Primary (A) and secondary (B) plots of reactivation of
the DFP-inhibited hAChE by K027.
Found at: doi:10.1371/journal.pone.0005957.s006 (0.94 MB TIF)
Figure S7 Compounds and atom ID definitions used in this
study.
Found at: doi:10.1371/journal.pone.0005957.s007 (0.76 MB TIF)
Dataset S1 A2C
Found at: doi:10.1371/journal.pone.0005957.s008 (0.47 MB
DOC)
Dataset S2 A3C
Found at: doi:10.1371/journal.pone.0005957.s009 (0.47 MB
DOC)
Dataset S3 I3Cr
Found at: doi:10.1371/journal.pone.0005957.s010 (4.50 MB
DOC)
Dataset S4 I3C
Found at: doi:10.1371/journal.pone.0005957.s011 (4.50 MB
DOC)
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